| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 4.17% | Canaccord Genuity | $9 → $0.4 | Downgrades | Buy → Hold |
| 05/31/2023 | 2243.75% | Canaccord Genuity | $12 → $9 | Maintains | Buy |
| 07/18/2022 | 1722.92% | BTIG | $8 → $7 | Maintains | Buy |
| 05/10/2022 | 1202.08% | Piper Sandler | $7 → $5 | Maintains | Neutral |
| 03/04/2022 | 3285.42% | Canaccord Genuity | $15 → $13 | Maintains | Buy |
| 03/04/2022 | 1722.92% | Piper Sandler | $16 → $7 | Downgrades | Overweight → Neutral |
| 01/07/2022 | 4066.67% | Credit Suisse | → $16 | Initiates Coverage On | → Outperform |
| 12/07/2021 | 3806.25% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
| 11/05/2021 | 3806.25% | Canaccord Genuity | → $15 | Initiates Coverage On | → Buy |
| 10/18/2021 | 3806.25% | BTIG | → $15 | Initiates Coverage On | → Buy |
| 10/07/2021 | 4066.67% | Piper Sandler | → $16 | Initiates Coverage On | → Overweight |
What is the target price for Vicarious Surgical (RBOT)?
The latest price target for Vicarious Surgical (NYSE: RBOT) was reported by Canaccord Genuity on November 14, 2023. The analyst firm set a price target for $0.40 expecting RBOT to rise to within 12 months (a possible 4.17% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vicarious Surgical (RBOT)?
The latest analyst rating for Vicarious Surgical (NYSE: RBOT) was provided by Canaccord Genuity, and Vicarious Surgical downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Vicarious Surgical (RBOT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vicarious Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vicarious Surgical was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
Is the Analyst Rating Vicarious Surgical (RBOT) correct?
While ratings are subjective and will change, the latest Vicarious Surgical (RBOT) rating was a downgraded with a price target of $9.00 to $0.40. The current price Vicarious Surgical (RBOT) is trading at is $0.38, which is out of the analyst's predicted range.